Literature DB >> 33452629

Therapeutic Advances in Movement Disorders.

Caroline M Tanner1,2, Jill L Ostrem3.   

Abstract

Entities:  

Year:  2021        PMID： 33452629      PMCID： PMC7810426          DOI： 10.1007/s13311-020-00988-2

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN： 1878-7479            Impact factor:   7.620


× No keyword cloud information.
  20 in total

Review 1.  Treatment of Disorders of Tone and Other Considerations in Pediatric Movement Disorders.

Authors:  Stephen R Deputy; Ann H Tilton
Journal:  Neurotherapeutics       Date:  2021-01-06       Impact factor: 7.620

Review 2.  Therapeutic Update on Huntington's Disease: Symptomatic Treatments and Emerging Disease-Modifying Therapies.

Authors:  Deepa Dash; Tiago A Mestre
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

Review 3.  Management of Tardive Syndrome: Medications and Surgical Treatments.

Authors:  Stewart A Factor
Journal:  Neurotherapeutics       Date:  2020-07-27       Impact factor: 7.620

Review 4.  Implementation of Mobile Health Technologies in Clinical Trials of Movement Disorders: Underutilized Potential.

Authors:  Carlo Alberto Artusi; Gabriele Imbalzano; Andrea Sturchio; Andrea Pilotto; Elisa Montanaro; Alessandro Padovani; Leonardo Lopiano; Walter Maetzler; Alberto J Espay
Journal:  Neurotherapeutics       Date:  2020-07-30       Impact factor: 7.620

Review 5.  Treatment of Dystonia: Medications, Neurotoxins, Neuromodulation, and Rehabilitation.

Authors:  Ian O Bledsoe; Aaron C Viser; Marta San Luciano
Journal:  Neurotherapeutics       Date:  2020-10-23       Impact factor: 7.620

Review 6.  Update on the Treatment of Ataxia: Medication and Emerging Therapies.

Authors:  Susan L Perlman
Journal:  Neurotherapeutics       Date:  2020-10-06       Impact factor: 7.620

Review 7.  Management of psychiatric disorders in Parkinson's disease : Neurotherapeutics - Movement Disorders Therapeutics.

Authors:  Daniel Weintraub
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

Review 8.  The Emerging Evidence of the Parkinson Pandemic.

Authors:  E Ray Dorsey; Todd Sherer; Michael S Okun; Bastiaan R Bloem
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

Review 9.  Gene and Cell-Based Therapies for Parkinson's Disease: Where Are We?

Authors:  Philip C Buttery; Roger A Barker
Journal:  Neurotherapeutics       Date:  2020-10-30       Impact factor: 7.620

Review 10.  Emerging Targeted Therapeutics for Genetic Subtypes of Parkinsonism.

Authors:  Susanne A Schneider; Baccara Hizli; Roy N Alcalay
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 6.088
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.